Co-Diagnostics, Inc. (OTC: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that ...
Clinical samples collected from patients for at-home testing are typically unprocessed, making them vulnerable to molecular inhibitors that can reduce signal strength and lower assay sensitivity. The ...
Because of its high accuracy, laboratory-based polymerase chain reaction (PCR) testing is the gold standard for infectious disease diagnostics. However, PCR technology requires highly trained staff ...
Company and CoSara believe that ISO certification is a critical component of the regulatory requirements for clearance of new ...
Expands range of applications for successful QIAcuity digital PCR platforms, now entering the clinical space across North America and the EU // Provides absolute quantitation, essential for precise ...
SUNNYVALE, Calif., Dec. 15, 2020 /PRNewswire/ -- Anitoa Systemc, LLC., market leader in rapid, portable PCR-based molecular testing, today announced the award of CE (Conformité Européene)-IVD Mark for ...
Given the highly infectious nature of the COVID pathogen, tests for the virus had to be quick, reliable and safe. The test ...
COVID-19 is commonly diagnosed by quantitative fluorescence real-time reverse transcriptase-polymerase chain reaction (qRT-PCR) (1, 2). The test is the sequential action of two enzymes–an ...
Roche’s cobas® BV/CV PCR assay aims to address frequent misdiagnosis of bacterial vaginosis and Candida vaginitis. The duplex test detects both conditions from one swab with high specificity, enabling ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results